ArticleeLife2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.
Rahul K Suryawanshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleeLife2025
Rahul K Suryawanshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.